gabexate has been researched along with Neoplasms in 4 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC." | 9.06 | Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988) |
| "The effects of gabexate mesilate on disseminated intravascular coagulation (DIC) accompanying neoplastic diseases or severe infections in ten patients were investigated and compared with those of heparin therapy in ten other patients with DIC." | 5.06 | Gabexate as a therapy for disseminated intravascular coagulation. ( Adachi, M; Soejima, R; Umeki, S; Watanabe, M; Yaji, S, 1988) |
| "Gabexate Mesilate was thought to be effective and free from complication in case 4, 5." | 1.28 | [Report of five cases of major surgery during anticoagulant therapy after prosthetic valve replacement]. ( Abe, T; Hagiwara, K; Hoshino, S; Igari, T; Iwatani, F; Midorikawa, H; Sadogawa, H; Sato, Y; Tanji, M; Watanabe, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammendola, M | 1 |
| Leporini, C | 1 |
| Marech, I | 1 |
| Gadaleta, CD | 1 |
| Scognamillo, G | 1 |
| Sacco, R | 1 |
| Sammarco, G | 1 |
| De Sarro, G | 1 |
| Russo, E | 1 |
| Ranieri, G | 1 |
| Midorikawa, H | 1 |
| Iwatani, F | 1 |
| Igari, T | 1 |
| Abe, T | 1 |
| Hagiwara, K | 1 |
| Tanji, M | 1 |
| Sadogawa, H | 1 |
| Watanabe, M | 2 |
| Sato, Y | 1 |
| Hoshino, S | 1 |
| Umeki, S | 1 |
| Adachi, M | 1 |
| Yaji, S | 1 |
| Soejima, R | 1 |
| Wada, H | 1 |
| Suzuki, H | 1 |
| Mori, Y | 1 |
| Deguchi, A | 1 |
| Oukubo, I | 1 |
| Tsuda, M | 1 |
| Tanaka, I | 1 |
| Deguchi, K | 1 |
| Shirakawa, S | 1 |
| Minami, N | 1 |
1 review available for gabexate and Neoplasms
| Article | Year |
|---|---|
Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy.
Topics: Angiogenesis Inhibitors; Cell Proliferation; Gabexate; Humans; Inflammation; Mast Cells; Neoplasms; | 2014 |
1 trial available for gabexate and Neoplasms
| Article | Year |
|---|---|
Gabexate as a therapy for disseminated intravascular coagulation.
Topics: Anticoagulants; Clinical Trials as Topic; Disseminated Intravascular Coagulation; Gabexate; Guanidin | 1988 |
2 other studies available for gabexate and Neoplasms
| Article | Year |
|---|---|
[Report of five cases of major surgery during anticoagulant therapy after prosthetic valve replacement].
Topics: Adult; Anticoagulants; Dipyridamole; Female; Gabexate; Guanidines; Heart Valve Prosthesis; Heparin; | 1990 |
[Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Heparin; Humans; Leuke | 1988 |